Results 51 to 60 of about 4,504,450 (222)

Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients

open access: yesCardiovascular Diabetology
Background Cardiovascular disease is a leading cause of post-transplant mortality in kidney transplant recipients (KTRs), especially those with diabetes.
Li-Chun Lin   +3 more
doaj   +1 more source

Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism

open access: yesEndocrine Journal
Pheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism.
Xurong Mai   +12 more
doaj   +1 more source

Urine diagnostics in paediatric intestinal failure: A prospective cohort study of alternative sampling methods

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Regular monitoring of urinary electrolyte excretion and kidney function is essential in children with intestinal failure (IF) receiving long‐term parenteral nutrition (PN). This study evaluated alternative urine sampling methods against 24‐h urine collection (UC) and assessed the prevalence of chronic kidney disease (CKD) and renal ...
Anna Sakaeva   +12 more
wiley   +1 more source

The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old

open access: yes, 2017
Objective: The diagnosis of primary aldosteronism (PA) among the older-aged population has posed a crucial challenge. Among patients over 50 years old, this trial assessed comparability of the performance of two PA diagnostic tests: losartan and ...
陳永銘;吳允升;王明鉅;謝月貞;吳寬墩   +1 more
core   +1 more source

Treatment of Primary Aldosteronism with mTORC1 Inhibitors [PDF]

open access: yes, 2019
mTORC1 activity is often increased in the adrenal cortex of patients with primary aldosteronism and mTORC1 inhibition decreases aldosterone production in adrenocortical cells, suggesting the mTORC1 pathway as a possible target for treatment of primary ...
Seelig, Eleonora   +33 more
core   +1 more source

Clinical characteristics of normal subjects and primary aldosteronism patients.

open access: yes, 2023
Clinical characteristics of normal subjects and primary aldosteronism patients.
Yuta Nakaniida (15361132)   +5 more
core   +1 more source

GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease

open access: yesNature Communications
Previous studies have explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing cardiovascular events in type 2 diabetes.
Heng-Chih Pan   +6 more
doaj   +1 more source

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background While both renin‐dependent and renin‐independent aldosterone secretion contribute to aldosteronism, their relative associations with cardiovascular disease (CVD) risk has not been investigated.
Jinbo Hu   +19 more
doaj   +1 more source

Glucocorticoids and HPA axis regulation in the stress–obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton   +4 more
wiley   +1 more source

Adrenal vein sampling in differential diagnosis of primary aldosteronism on the example of a clinical case

open access: yes, 2019
Primary aldosteronism is the most common cause of endocrine hypertension, occurring in 5–10% of patients with hypertension. Convincing evidence has been obtained indicating that primary aldosteronism increases the risk of cardiovascular complications ...
Ivan I. Sitkin   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy